|
|
|
| Types and Applications of Tissue Engineering Products |
| WANG Dian-liang |
| Tissue Engineering and Regenerative Medicine Laboratory, The Second Artillery General Hospital, Beijing 100088, China |
|
|
|
Abstract The products of tissue engineering include artificial skin, blood vessel, cartilage, bone, cornea, cardiac valves, trachea, tendon, ligament, nerve, muscle, bone marrow, genital tract, urethral canal, intestine, breast, liver, kidney, pancreas, heart, bladder and hand, etc. Most of these products are in a stage of laboratory investigation exploration; less products are carrying out clinic test or ratified clinic application. The authorized tissue engineering products mainly include skin products, cartilage and bone products, cardiovascular products, nervous system products and artificial organs, etc., which are usually applied in clinic. More and more tissue engineering products will be emerged in future, and the clinic use of tissue engineering products will be more and more extensive.
|
|
Received: 29 September 2014
Published: 25 November 2014
|
|
|
|
|
|
[1] Pirnay J P, Vanderkelen A, De Vos D, et al. Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems. Cell Tissue Bank, 2013,14(4):525-560.
[2] Lewandowska-Szumiel M, Wójtowicz J. Bone tissue engineering - a field for new medicinal products? Curr Pharm Biotechnol, 2011,12(11):1850-1859.
[3] Berthiaume F, Maguire T J, Yarmush M L.Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng, 2011,2:403-430.
[4] Barai N D, Boyce S T, Hoath S B, et al.Improved barrier function observed in cultured skin substitutes developed under anchored conditions. Skin Res Technol, 2008,14(4):418-424.
[5] Pan Y, Chu T, Dong S, et al. Cells scaffold complex for Intervertebral disc Anulus Fibrosus tissue engineering: in vitro culture and product analysis. Mol Biol Rep, 2012,39(9):8581-8594.
[6] Zhou H Z, Yu H, Xue Y. In vivo self-expanding engineering of bone. Med Hypotheses, 2009,73(4):528-530.
[7] Inoue H. The present situation and future prospects of bone substitute of bioinspired materials.Clin Calcium, 2008, 18(12):1729-1736.
[8] Tedder M E, Simionescu A, Chen J, et al. Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering. Tissue Eng Part A, 2011,17(1-2):25-36.
[9] Schmedlen R H, Elbjeirami W M, Gobin A S, et al. Tissue engineered small-diameter vascular grafts. Clin Plast Surg, 2003,30(4):507-517.
[10] Noishiki Y, Yamane Y, Okoshi T, et al. Choice, isolation, and preparation of cells for bioartificial vascular grafts. Artif Organs, 1998,22(1):50-62.
[11] Cho H J, Lee H J, Chung Y J, et al. Generation of human secondary cardiospheres as a potent cell processing strategy for cell-based cardiac repair. Biomaterials, 2013,34(3):651-661.
[12] Shazly T, Kolachalama V B, Ferdous J, et al.Assessment of material by-product fate from bioresorbable vascular scaffolds. Ann Biomed Eng, 2012,40(4):955-965.
[13] Daadi M M, Steinberg G K. Manufacturing neurons from human embryonic stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy. Regen Med, 2009,4(2):251-263.
[14] Magin R L. Fractional calculus in bioengineering, part 3. Crit Rev Biomed Eng,2004,32(3-4):195-377.
[15] Yannas I V, Hill B J. Selection of biomaterials for peripheral nerve regeneration using data from the nerve chamber model. Biomaterials, 2004,25(9):1593-1600.
[16] Lenas P, Luyten F P, Doblare M, et al.Modularity in developmental biology and artificial organs: a missing concept in tissue engineering. Artif Organs, 2011, 35(6):656-662.
[17] Guthke R, Zeilinger K, Sickinger S, et al. Dynamics of amino acid metabolism of primary human liver cells in 3D bioreactors. Bioprocess Biosyst Eng, 2006,28(5):331-340.
[18] Kim H L, Lee J H, Lee M H, et al. Evaluation of electrospun (1,3)-(1,6)-β-D-glucans/biodegradable polymer as artificial skin for full-thickness wound healing. Tissue Eng Part A, 2012,18(21-22):2315-2322.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
